Emerald Advisers, LLC Ptc Therapeutics, Inc. Transaction History

Emerald Advisers, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 28, 2020	SELL	$42.56 - $54.98 $6.27 Million - $8.1 Million	-147,280 Closed	0 $0
Q1 2020 Apr 30, 2020	SELL	$32.37 - $59.36 $7.53 Million - $13.8 Million	-232,508 Reduced 61.22%	147,280 $6.57 Million
Q4 2019 Jan 29, 2020	BUY	$32.22 - $50.07 $253,893 - $394,551	7,880 Added 2.12%	379,788 $18.2 Million
Q3 2019 Oct 31, 2019	SELL	$33.82 - $48.17 $544,569 - $775,633	-16,102 Reduced 4.15%	371,908 $12.6 Million
Q2 2019 Jul 31, 2019	BUY	$35.42 - $45.0 $3.14 Million - $3.99 Million	88,579 Added 29.58%	388,010 $17.5 Million
Q1 2019 May 01, 2019	BUY	$28.09 - $39.49 $2.19 Million - $3.08 Million	77,928 Added 35.18%	299,431 $11.3 Million
Q4 2018 Jan 30, 2019	SELL	$29.83 - $46.51 $117,739 - $183,574	-3,947 Reduced 1.75%	221,503 $7.6 Million
Q3 2018 Oct 31, 2018	BUY	$33.9 - $47.77 $7.64 Million - $10.8 Million	225,450 New	225,450 $10.6 Million

223

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.03B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Emerald Advisers, LLC with notifications on news.